Browsing by Author Vergote, Ignace

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2011Clinical Trials in Recurrent Ovarian CancerBeale, Philip; Alberts, David; Avall-Lundqvist, Elisabeth; Brady, Mark; et al, various; Friedlander, Michael; Harter, Philipp; Pignata, Sandro; Pujade- Lauraine, Eric; Sehouli, Jalid; Tinker, Anna; Trimble, Edward; Vergote, Ignace; Central Clinical School: MedicineClinical Trials in Recurrent Ovarian Cancer, International Journal Of Gynecological Cancer, vol.21, 4, 2011,pp 771-775
2011Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.Brown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Delva, Remy; Donadello, Nicoletta; Friedlander, Michael L.; Georgoulopoulos, Alexander; Mirza, Mansoor Raza; Pignata, Sandro; Pujade-Lauraine, Eric; Schmalfeldt, Barbara; Southier, Philippe; Vergote, Ignace; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreEarly Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer., Journal of the National Cancer Institute, vol.103, 17, 2011,pp 1338-1342
2015Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trialGebski, Val; Lee, Chee Khoon; Lord, Sarah (Sally); Ferrero, A.; Friedlander, Michael; Grunewald, Tami; Hardy-Bessard, Anne Claire; Harter, Philipp; Heywood, M; Pujade-Lauraine, Eric; Scambia, G; Schauer, C; Sehouli, Jalid; Vergote, Ignace; Woie, Kathrine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreImpact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial, Gynecologic Oncology, vol.136, 1, 2015,pp 18-24
2010Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late RelapseBrown, Christopher; Gebski, Val; Aavall-Lundqvist, Elisabeth; du Bois, Andreas; Ferrero, Annamaria; Heywood, Mark; Jackisch, Christian; Joly, Florence; Kristensen, Gunnar; Le Fur, Nathalie; Lortholary, Alain; Pignata, Sandro; Pujade-Lauraine, Eric; Sehouli, Jalid; Vasey, Paul A.; Vergote, Ignace; Volgger, Birgit; Wagner, Uwe; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse, Journal of Clinical Oncology, vol.28, 20,pp 3323-3329
2011Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancerBrown, Christopher; Gebski, Val; Lee, Chee; Lord, Sarah (Sally); Simes, Robert John; Angleitner-Boubenizek, L.; Bentley, J.; Bourgeois, H.; Burges, A.; Ferrero, A.; Friedlander, Michael; Hirte, H.; Hogberg, T.; Parma, G.; Pfisterer, J.; Pisano, C.; Plante, M.; Pujade-Lauraine, Eric; Richter, B.; Vergote, Ignace; Wagner, U.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePrognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer, British Journal of Cancer, vol.105, 8, 2011,pp 1144-1150
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165